menu
    • menu

    Company profile for EspeRare

    NEW Drugs in Dev: 2
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    EspeRare is a nonprofit organisation established in Switzerland in 2013. It is recognised to be operating in the public's interest.We dream of a world in which patient engagement, good science, pharmaceutical excellence and health authorities come together to address the medical needs of rare diseases patients, ultimately alleviating the healthcare burden of their conditions.In collaboration with patient groups and other key s...
    EspeRare is a nonprofit organisation established in Switzerland in 2013. It is recognised to be operating in the public's interest.We dream of a world in which patient engagement, good science, pharmaceutical excellence and health authorities come together to address the medical needs of rare diseases patients, ultimately alleviating the healthcare burden of their conditions.In collaboration with patient groups and other key stakeholders, we uncover the potential of existing therapies to address severe therapeutic unmet needs in rare diseases.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    EspeRareSwitzerland Flag
    Country
    Country
    Switzerland
    Address
    Address
    Campus Biotech-EPFL Innovation Park Avenue Secheron 15 1202 Geneva
    Telephone
    Telephone
    +41 22 794 40 04
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://esperare.org/en
    Linkedin
    Linkedin
    https://www.linkedin.com/company/esperare-foundation
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    BPI Europe

    BPI Europe

    Not Confirmed

    envelop Contact Supplier

    BPI Europe

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    PacBio to Partner With n-Lorem, EspeRare on Rare Diseases
    PacBio to Partner With n-Lorem, EspeRare on Rare Diseases

    12 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/12/3217022/16261/en/PacBio-Announces-Plans-for-Collaboration-With-n-Lorem-Foundation-and-EspeRare-to-Advance-Precision-Therapies-for-Rare-Genetic-Diseases.html

    GLOBENEWSWIRE
    12 Jan 2026
    Share Share
    N-Lorem, Esperare Collaborate To Expand Access To ASO Therapies
    N-Lorem, Esperare Collaborate To Expand Access To ASO Therapies

    12 Jan 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/n-lorem-and-esperare-announce-european-collaboration-to-expand-access-to-individualized-aso-therapies-for-rare-genetic-diseases-302658829.html

    PR NEWSWIRE
    12 Jan 2026
    Share Share
    EspeRare Secures Gates Grant to Advance Preeclampsia Therapy
    EspeRare Secures Gates Grant to Advance Preeclampsia Therapy

    03 Dec 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/esperare-receives-a-grant-from-the-gates-foundation-to-advance-a-novel-therapy-for-preeclampsia-302632071.html

    PR NEWSWIRE
    03 Dec 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search